NCT05198830 2026-05-27Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Recruiting42 enrolled